2023-508793-29-00招募中1 期
A study in subjects with gout flares that investigates the effect, safety, tolerability, and pharmacokinetics (absorption, distribution, metabolism, and elimination) of a single dose of LEO 158968, a new compound that may potentially be used in the treatment of several autoinflammatory diseases
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 13
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Global Clinical Development
Scientific
Leo Pharma A/S
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Real-time monitoring the occurrence of gout flares in patients by incorporation of the 2017 gout flare definition into an eHealth platform. A feasibility studygout / jichtself-diagnosis / zelf-diagnoseeHealthNL-OMON21867Sint Maartenskliniek Nijmegen30
已完成
不适用
Real-time monitoring the occurrence of gout flares in patients by incorporation of the 2017 gout flare definition into an eHealth platform: a feasibility study.NL-OMON45981Sint Maartenskliniek30
暂停
2 期
Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal TransplantationGoutRenal TransplantationChronic Kidney DiseaseNCT04844814Assistance Publique - Hôpitaux de Paris204
终止
4 期
Prednisolone Versus Colchicine for Acute Gout in Primary CareAcute GoutNCT05698680University Medicine Greifswald186
尚未招募
Phase 3 4
MANAGEMENT OF GOUT WITH AYURVEDIC MEDICINE RECTAL ADMINISTRATION PROCEDURECTRI/2021/09/036419Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur45